Schedule a Meeting
Download Brochure
Table of Content
March 2025
The global fertility market size is calculated at USD 36.57 billion in 2024, grew to USD 39.88 billion in 2025, and is projected to reach around USD 87.05 billion by 2034. The market is expanding at a CAGR of 9.06% between 2025 and 2034. The growing awareness of IVF, the rising adoption of assisted reproductive technologies (ARTs), and the escalating rates of infertility globally are anticipated to drive market expansion shortly. Moreover, the presence of different treatment alternatives is expected to enhance the fertility market throughout the forecast period.
Unlock Infinite Advantages: Subscribe to Annual Membership
Fertility refers to the inherent capability of an organism to attain a clinical pregnancy via a complex biological mechanism called reproduction, aided by the reproductive system, to generate offspring and ensure the continuation of the species. The increasing prevalence of infertility globally is a significant contributor to market expansion. Major factors contributing to infertility involve lifestyle alterations such as unhealthy eating and obesity, stress, and alcohol use, along with medical issues like polycystic ovary syndrome (PCOS), endometrial tuberculosis, and sexually transmitted infections (STIs). Additionally, due to late pregnancy, the declining egg quality in aging women contributes to infertility rates. According to WHO estimation for 2024, approximately 1 in every 6 people of reproductive age will experience infertility for a lifetime worldwide. The market is experiencing substantial innovation, primarily fueled by progress in ART techniques such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). These enhancements are expanding treatment choices and elevating success rates, consequently raising the demand for the fertility market.
AI, especially machine learning (ML), is revolutionizing the fertility industry by improving diagnostics, personalizing treatments, and increasing success rates. ML algorithms can evaluate genetic, medical, and lifestyle information to forecast fertility problems and customize personalized treatment strategies. In IVF, machine learning enhances embryo selection, raising success rates and minimizing the number of cycles needed. Apps and wearables powered by AI provide real-time tracking of fertility, utilizing data to forecast ovulation and identify hormonal imbalances. Moreover, AI-powered genomic analysis aids in customized therapies and embryo selection, minimizing genetic risks. AI decreases treatment costs and enhances accessibility by automating routine tasks, resulting in more efficient fertility care. Nonetheless, as AI increasingly integrates into fertility, ethical issues like data privacy, discrimination, and oversight of decisions must be considered. Guaranteeing transparency and oversight will be essential for the safe and effective application of fertility practices.
Rising Need for Assisted Reproductive Technology (AST)
The need for sophisticated fertility procedures such as IVF, IUI, and IVF without intracytoplasmic sperm injection (ICSI) is continually increasing. This rise is mainly attributed to reasons like later childbearing, increased awareness of fertility choices, and ongoing advancements in reproductive technology. Moreover, shifting societal standards, changing lifestyle preferences, and the increasing demand for family planning assistance are encouraging more people and couples to seek fertility treatments, leading to a heightened need for these services.
The phenomenon of women giving birth later in life, usually after the age of 35, is known as "advanced maternal age" or postponed childbearing. In recent years, this trend has gained popularity in numerous developed nations because of different social, economic, and cultural influences. Nonetheless, postponing childbirth can profoundly impact both individuals and society. Women opting to have children at a later age might encounter an increased risk of complications such as miscarriage, pregnancy problems, and genetic disorders in their offspring. Consequently, there has been an increase in the demand for fertility services and treatments like IVF, egg freezing, and various reproductive technologies to assist individuals delaying parenthood.
High-Cost Fertility Treatment
The steep expense of fertility procedures, especially IVF, poses a significant financial obstacle for numerous individuals. Due to limited insurance coverage and considerable differences, these treatments may discourage individuals from seeking assistance. Certain individuals can manage to pay for just one or two treatment cycles, diminishing their likelihood of achieving success. Stress, a significant contributor to fertility issues, can also have a detrimental impact, and infertility treatments can be exhausting emotionally. This emotional pressure can additionally influence the success of the therapies. Moreover, in specific areas, particular reproductive methods are governed by legal or ethical standards, constraining the choices accessible to individuals seeking help. IVF therapy is a major financial strain because it typically costs between $11,000 and $18,000 each cycle, including diagnostics and medication.
Opportunity
Medical Regeneration and Stem Cell Treatment
Researchers are investigating stem cell therapy as a possible remedy for women experiencing early ovarian failure or diminished ovarian reserve. Stem cells may be introduced into the ovaries to encourage the growth of new follicles and enhance ovarian performance. These stem cells can originate from different sources, including bone marrow or adipose tissue. Moreover, researchers are investigating stem cells' capability to restore and heal the endometrium (the lining of the uterus). This may help women suffering from issues such as Asherman's syndrome, which leads to infertility or recurrent miscarriages, or those with a thin endometrium. Stem cell therapy is under research as a potential solution for male infertility, given that spermatogonia stem cells can be cultivated and collected in vitro.
By offering, the assisted reproductive technology segment registered its dominance over the global fertility market in 2024. Due to ART methods such as IUI, ICSI, and IVF, a wider variety of people now enjoy improved access to fertility services. This has resulted in the expansion of the fertility clinic market and associated services. Improvements in ART methods have also lowered the risks linked to reproductive therapies while enhancing success rates. Advancements like time-lapse imaging of embryos, vitrification of eggs and embryos, and preimplantation genetic testing (PGT) have improved results for patients. The demand for ART services has risen because of reasons such as the growing occurrence of same-sex parenthood, postponed childbearing, and infertility caused by medical interventions. The increasing application of ART has generated ethical issues, such as the disposal of embryos, the selection of genetic characteristics, and the commercialization of human reproduction.
By offering, the fertility drugs segment is expected to grow at a significant rate in the fertility market during the forecast period. Due to its accessibility and comparatively cheaper cost when compared to more involved treatments like IVF, more people are using fertility medicines as a first treatment choice as knowledge of reproductive concerns grows. Additionally, fertility medications are less intrusive, which appeals to couples looking for easier, non-invasive procedures. Fertility drugs are now a more dependable option for many people due to improvements in drug formulations and increased efficacy. The need for these therapies is also being driven by lifestyle factors, delayed childbirth, and increased infertility rates.
Clomid, which is frequently used to induce ovulation in women with irregular cycles, is an example of the growing need for fertility medications. Similarly, for women who do not react to oral medicines, injectable gonadotropins are used to increase ovulation. These medications are more common than more costly procedures like IVF since they provide a less intrusive and more economical alternative.
By end-user, the fertility clinics segment held a dominant presence in the fertility market in 2024. Fertility clinics are essential in the reproductive sector by providing a range of services to individuals and couples facing infertility challenges. These services encompass sperm donation, egg preservation, fertility evaluation, IUI, and IVF. The fertility industry has expanded swiftly in recent years due to reasons such as postponed parenthood, heightened awareness of fertility options, and progress in reproductive technology. Consequently, fertility clinics have grown worldwide, encompassing both large, specialized facilities and smaller, independent practices.
For instance,
By end-user, the hospital segment is projected to grow at a significant rate during the coming years. Specialized fertility clinics can operate independently or are commonly located in hospitals. These clinics provide numerous treatments, such as IVF, IUI, fertility exams, and further reproductive therapy. For individuals undergoing medical treatments like chemotherapy or radiation that may affect their fertility, hospitals provide fertility preservation procedures, such as freezing sperm or eggs. Hospitals typically collaborate with reproductive specialists, including endocrinologists, embryologists, and fertility doctors, to offer state-of-the-art fertility treatments. Additionally, hospitals offer educational resources, support groups, and counseling to help individuals and couples deal with infertility concerns.
Europe dominated globally and held the largest share of 34% in the fertility market in 2024. In recent years, the need for fertility treatments has increased throughout Europe, fueled by factors such as evolving lifestyles, postponed childbearing, and rising infertility rates. Fertility treatment laws differ across countries, with certain nations maintaining more lenient regulations that permit various reproductive services, whereas others enforce tighter rules. Across Europe, many fertility clinics offer services that include advanced reproductive treatments as well as fundamental fertility assessments. These clinics frequently offer tailored care and assistance for individuals and couples receiving treatment. Owing to variations in regulations and expenses among countries, certain individuals might opt to pursue fertility treatments overseas, visiting another European country for care.
In Germany, businesses are increasingly utilizing digital technology to promote market expansion, the expansion of the market in Germany is fueled by innovations in medical technology, increased awareness of infertility and treatment options, and elevated success rates for IVF. The National Library of Medicine reports that approximately 3% of children in Germany are conceived via in vitro fertilization (IVF), emphasizing the growing dependence on this reproduction method. For instance, in April 2024, the Berlin-based fertility company Ovom Care secured $5.34 million in seed funding to improve its Ovom Technology Ecosystem and grow its hybrid care model nationwide.
The market is driven large by encouraging government programs, favorable government laws, regulations, and rising investments. In January 2024, the French government proposed offering complimentary fertility tests for 25-year-olds as part of routine health checkups to address rising infertility rates and declining birth rates. Additionally, in June 2023, France passed a law allowing single women and same-sex couples to access IVF and other fertility treatments. This reform, which received widespread public support, enables women to pursue fertility care without the need for a male partner, making fertility services more inclusive in the country.
Asia-Pacific is anticipated to grow at the fastest rate in the fertility market during the forecast period. The increasing demand for fertility treatments is due to postponed childbearing, shifts in lifestyle, and the rising incidence of infertility problems. Improvements in assisted reproductive technologies (ART), including ICSI, PGT, and IVF, have increased the accessibility and effectiveness of fertility treatments. In the Asia Pacific area, governmental financial aid and subsidies are assisting in making these treatments more economical for couples. Heightened awareness of reproductive health matters and the reduction of stigma surrounding infertility have resulted in more individuals looking for assistance. Furthermore, numerous nations are revising their ART regulations to ensure treatments are more accessible and inclusive for a broader variety of people.
The National Health Commission has published guidelines aimed at enhancing fertility rates in China, with continuous talks about increasing access to fertility services for single women. These efforts are anticipated to further boost demand in China’s expanding fertility services market. In June 2023, Beijing declared that beginning July 1, 16 categories of assisted reproductive technologies would be included in its healthcare system. This initiative seeks to address China’s falling birth rate, which fell to a historic low of 6.77 births for every 1,000 individuals last year. The treatments that are covered consist of in vitro fertilization (IVF) and embryo transfer.
The expansion of the market is influenced by various crucial elements, such as improvements in assisted reproductive technologies, the emergence of fertility tourism, enhanced government backing, and heightened awareness of fertility therapies. Moreover, there is an increasing acceptance of IVF as a practical choice for couples seeking to conceive, along with the rising incidence of infertility cases. In February 2024, the Maharashtra government declared that it would provide free IVF treatments at certain government hospitals, a service that usually costs more than ₹2 lakh in private facilities. This program seeks to address infertility issues throughout the state, ensuring that IVF is available to numerous couples, including those living in rural communities. This action aims to instill hope in infertile couples by offering cutting-edge fertility treatments for free, irrespective of their financial circumstances.
In 2023, North America comprised a substantial portion of the fertility services market, ranking as the notable area by market size. The area provides key players for major participants, fueled by elements like a significant population, heightened understanding of fertility therapies, the rising appeal of IVF, increasing infertility statistics, and the tendency towards postponed pregnancies. Moreover, North America has experienced significant investments and technological progress in fertility services, which has further driven market expansion.
The U.S. dominates the market, bolstered by government programs. In April 2023, the federal government introduced a benefits program for its employees, providing a median lifetime benefit of $20,000 for fertility treatments. Employees have the option to choose plans that provide coverage for a range of fertility services, offering up to $25,000 each year for IVF and up to three artificial insemination cycles annually, thus enhancing access to fertility treatments.
The worldwide fertility services market has experienced significant growth lately, driven by developments in medical technology, changing social norms, and increased awareness of infertility issues. Fertility services encompass a wide array of treatments, including basic assessments and counseling, as well as more complex procedures such as IVF and genetic testing. Infertility has emerged as a major public health issue worldwide, impacting roughly 15% of couples. The World Health Organization (WHO) reports that infertility rates are increasing because of factors like lifestyle decisions, postponed marriage, environmental factors, and health issues.
In January 2025, according to Gameto co-founder Dina Radenkovic, Fertilo offers families a potentially quicker, safer, and more affordable option by addressing the main drawbacks of traditional IVF, including protracted treatment cycles, serious side effects, and mental and physical strain. In addition to highlighting the first use of iPSC technology in IVF and the enormous potential of our technique, this milestone represents a turning point in reproductive health.
By Offering
By End-user
By Region
March 2025
March 2025
February 2025
February 2025